OVERVIEW OF THE SAFETY OF FELODIPINE BASED ON CLINICAL-TRIALS IN PATIENTS WITH HYPERTENSION

Authors
WELIN L ELVELIN L NIKLASSON A OLSSON G ELMFELDT D
Citation
L. Welin et al., OVERVIEW OF THE SAFETY OF FELODIPINE BASED ON CLINICAL-TRIALS IN PATIENTS WITH HYPERTENSION, The American journal of cardiology, 79(7), 1997, pp. 996
Citations number
14
Categorie Soggetti
Cardiac & Cardiovascular System
Journal title
The American journal of cardiology → ACNP
ISSN journal
00029149
Volume
79
Issue
7
Year of publication
1997
Database
ISI
SICI code
0002-9149(1997)79:7<996:OOTSOF>2.0.ZU;2-2
Abstract
All clinical studies of at least 1 week's duration with felodipine in patients with hypertension were included in a safety analysis. The maj or finding was that felodipine does not increase mortality or the inci dence of major cardiovascular events and that the data indicate a favo rable effect.